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Abstract
Background: Previous studies from our own and other labs reported the surprising finding that the soluble V
domain of the herpes simplex virus type 1 (HSV-1) entry receptor nectin-1 can both block HSV infection of
receptor-bearing cells and mediate infection of receptor-deficient cells. Here we show that this property is not
unique to nectin-1. We generated a pair of truncated, soluble forms of the other major HSV-1 entry receptor,
herpes virus entry mediator (HVEM or HveA), and examined its effects on HSV-1 infection of receptor-deficient cells.
Results: In cultures of CHO-K1 cells, sHveA102 comprising the two amino-terminal cysteine-rich pseudorepeats
(CRPs) of HVEM enabled infection of greater than 80% of the cells at an MOI of 3, while sHveA162 comprising the
complete ectodomain failed to mediate infection. Both sHveA102 and sHveA162 blocked infection of CHO-K1 cells
stably expressing HVEM in a dose-dependent manner, indicating that both were capable of binding to viral gD. We
found that sHveA102-mediated infection involves pH-independent endocytosis whereas HSV infection of HVEM-
expressing CHO-K1 cells is known to be pH-dependent.
Conclusions: Our results suggest that the C-terminal portion of the soluble HVEM ectodomain inhibits gD
activation and that this effect is neutralized in the full-length form of HVEM in normal infection.
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Background
Herpes simplex virus type 1 (HSV-1) infects a broad
range of mammalian cells, including epithelial cells, lym-
phocytes, and post-mitotic neurons. Initial HSV attach-
ment to host cells is mediated by the binding of viral
envelope glycoproteins C (gC) and gB to ubiquitous
heparan sulfate moieties on the surface of cells [1-3].
While not essential [4], these interactions facilitate the
binding of glycoprotein D (gD) to one or more of its cog-
nate cell-surface receptors, nectin-1 (HveC), HVEM
(HveA), and 3-O-sulfated heparan sulfate (3-OS HS)
[5-7]. Binding to these entry receptors causes conforma-
tional changes in the gD ectodomain that signal activa-
tion of the downstream effectors of HSV entry, gB and
gH/gL, the proximal mediators of membrane fusion and
capsid delivery into the cytoplasm [8-12]. Recent studies
have also demonstrated that PILRa (paired immunoglo-
bulin-like type-2 receptor) and non-muscle myosin heavy
chain IIA can function as HSV-1 entry co-receptors
through interaction with gB [13,14].
The absolute dependence of HSV-1 infection on gD
binding to a cognate receptor indicates that the tropism
of the virus is determined at least in part by the distribu-
tion of gD receptors. Nectin-1 is a member of the immu-
noglobulin superfamily and is expressed on many cell
types, including fibroblasts, epithelial cells and neurons
[15]. Nectins function as intercellular adhesion molecules
localized to cadherin-based adherens junctions [16]. The
variable (V) domain of nectin-1 is sufficient for binding
to gD and the initiation of fusion between the virus
envelope and cell membranes [17]. HVEM is a member
of the tumor necrosis factor receptor (TNFR) superfamily
and is expressed in hematopoietic cells and lymphoid tis-
sues such as spleen and thymus [18,19]. HVEM contains
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properly cited.four cysteine-rich pseudorepeats (CRPs) characteristic of
members of the TNFR family in its ectodomain and func-
tions as a mediator of HSV-1 and HSV-2 entry mainly
into human lymphocytes [6,19]. The natural ligands for
HVEM include LIGHT, lymphotoxin alpha (Lt-a), B-
and T-lymphocyte attenuator (BTLA), and CD160 [20].
The contribution of the third gD receptor, 3-OS HS, to
the broad HSV-1 tropism is not as clearly defined since
this glycosaminoglycan modification is not easily detect-
able by immunological or other methods. However, novel
approaches are beginning to reveal the role of this recep-
tor [21].
X-ray crystallography has shown that HVEM binds to a
flexible hairpin at the amino terminus of gD [8]. A variety
of mutations in this region, including Q27P originally
identified in KOS-rid1 virus [22], abolish HVEM binding
[23,24]. Using a series of truncated forms of HVEM, Whit-
beck and colleagues demonstrated that the two N-terminal
CRPs of HVEM are required and sufficient for binding to
HSV-1 gD [25]. In their study, HveA(120 t), consisting of
the first and second CRP, showed full gD binding activity
by competition ELISA and blocked HSV entry into CHO
cells expressing HVEM.
We previously reported that the V-domain of nectin-1
as a soluble form can mediate efficient virus entry into
HSV-resistant CHO-K1 cells that lack gD receptors [26].
Here, we have investigated whether soluble forms of the
HVEM ectodomain have a similar ability. To this end, we
constructed soluble recombinant proteins consisting of
the first two CRPs (sHA102) or the full ectodomain
(sHA162) of HVEM. While both soluble proteins inhibited
HSV infection of HVEM-expressing CHO-K1 cells, only
sHA102 mediated virus entry into receptor-negative CHO-
K1 cells. Infection mediated by sHA102 was highly efficient,
involved specific binding of sHA102 to viral gD, required
heparin-sensitive virus attachment to the cells, and took
place by a pH-independent endocytic mechanism as
opposed to the pH-dependent mechanism mediating HSV
infection of HVEM-expressing CHO cells [27]. Our results
indicate that the C-terminal portion of the HVEM ectodo-
main contains sequences that inhibit gD activation and
suggest a context effect allowing gD activation by full-
length HVEM, but not the soluble ectodomain, in the
acidic milieu of endosomes.
Results
Production of soluble gD receptors
We constructed expression plasmids for two His6-tagged
soluble HVEM proteins, sHA102 containing the gD-bind-
ing first two CRPs (102 aa), and sHA162 comprising the
full ectodomain (162 aa) (Figure 1A). Soluble proteins
were produced by transfection of 293 T cells and purified
from the culture supernatant, as previously described [26].
The molecular size sHA102 was approximately 15 kDa
(Figure 1B, C), somewhat larger than the predicted size of
11 kDa most likely due to N-linked glycosylation in CRP2
[28]. sHA162 migrated predominantly as a 38 kDa species,
significantly larger than the predicted 18 kDa for the
monomeric form, suggesting incomplete denaturation of
the dimeric form that predominates in solution [28].
Soluble HVEM-mediated HSV-1 infection of CHO-K1 cells
We determined whether sHA102 and sHA162 could med-
iate HSV-1 entry into CHO-K1 cells that are resistant to
infection due to the absence of entry receptors. KOS/tk12,
expressing LacZ from the viral thymidine kinase (tk) locus
in a wild-type (strain KOS) viral background [29], was pre-
incubated at a multiplicity of 3 pfu/cell with CHO-K1 cells
in suspension for 1 h at 4°C. Increasing concentrations (0-
1,000 nM) of sHA proteins were then added and the cells
were incubated for 1 h at 37°C, plated, and incubated for
another 7 h at 37°C prior to measurement of b-galactosi-
dase activity by quantitative ONPG assay. As shown in
Figure 2A, dose-dependent infection was observed in the
presence of sHA102, whereas sHA162 failed to mediate
infection. At an MOI of 9, infection reached a plateau at
500 nM sHA102 (Figure 2B), suggesting that either the
amount of virus or the number of cells became limiting at
this concentration. A similar level of infection was
observed at an MOI of 3 with 1,000 nM sHA102, arguing
for the second interpretation. Indeed, titration of X-gal
stained cells showed infection of 90-100% of the cells at an
MOI of 9 at 500-1,000 nM sHA102 (Figure 2C). These
results demonstrated that the known gD binding region of
HVEM consisting of CRPs 1 and 2 was sufficient to med-
iate HSV entry into receptor-deficient cells. As shown in
Figure 2D, the efficiency of sHA102-mediated entry was
comparable to that mediated by the soluble V domain of
nectin-1 (sNec123) described previously [26].
Soluble HVEM blocks HSV infection of HVEM-expressing
CHO cells
Soluble forms of HVEM and nectin-1 have been shown to
inhibit HSV-1 entry through the cognate cellular receptors
by competition for gD binding [28]. To determine whether
the distinct entry-mediating activities of our sHA102 and
sHA162 preparations correlated with their ability to inhibit
virus entry via HVEM, we carried out competitive inhibi-
tion assays on CHO cells expressing HVEM. Cells were
infected with KOS/tk12 in the presence of soluble gD
receptors and b-galactosidase expression was measured by
ONPG assay. As shown in Figure 4, expression decreased
with increasing amounts of sHA102 and sHA162, indicating
dose-dependent entry inhibition. While 1,000 nM of
sHA102 was required to inhibit KOS/tk12 infection by
approximately 50%, sHA162 reached this level of inhibition
at 250 nM. The greater blocking efficiency of sHA162 is in
sharp contrast to its lack of entry-mediating activity on
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CRP 3 and 4, when not anchored in the cell membrane,
sterically limit the activation of gD involving partial
unfolding to expose its effector/pro-fusion domain [10,12].
Specific interaction of sHA102 with viral gD
We determined whether sHA102-mediated virus entry into
CHO-K1 cells requires specific interaction with gD. As
illustrated in Figure 3, while sHA102 promoted entry of
KOS/tk12 into CHO-K1 cells, little entry was observed by
an isogenic mutant virus, KOS-Rid1/tk, that has an
amino-acid substitution in gD preventing interaction with
HVEM [29]. In addition, we observed that preincubation
of sHA102 with soluble gD ectodomain (gD287; Figure. 1C)
inhibited virus entry into CHO-K1 cells in a sgD287 dose-
dependent manner. When the concentration of sHA102
was augmented up to 100 nM, the viral infection was
recovered to 2 fold (Figure 3). Together, these results indi-
cated that sHA102-mediated HSV entry into CHO-K1 cells
occurred through specific binding to viral gD.
Requirement of heparan sulfate binding for sHA102-
mediated infection
HSV attachment is mediated by the binding of gB and
gC to cell-surface glycosaminoglycans, particularly
heparan sulfate [30]. To determine whether heparan sul-
fate binding was required for sHA102-mediated HSV
entry, infections were performed in the presence of 25
μg / m lh e p a r i n .A ss h o w ni nF i g u r e5 ,i n f e c t i o nw a s
reduced at all MOIs tested, including more than 200-
fold at an MOI of 10. These results indicated that virus
attachment to cell-surface heparan sulfate is necessary
for efficient sHA102-mediated HSV entry, as previously
observed for soluble nectin-1-mediated infection [26].
Figure 1 Structure and expression of soluble HVEM proteins. (A) Schematic representations of full-length HVEM (HveA) and the truncated
HVEM proteins produced for this study. Lollipops indicate glycosylation sites and numbers indicate amino acid positions relative to position 1 of
mature HVEM. CRP, cysteine-rich pseudorepeat; H6, six-histidine tag. (B) Silver-stained SDS-PAGE gels of soluble protein samples. (C) Western blot
detection of purified recombinant soluble proteins using anti-His tag antibody. Lane 1, sHA102; lane 2, sHA162; lane 3, sNec1123 used in Figure 2D;
lane 4, sgD287 used in Figure 3.
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Page 3 of 10Figure 2 Soluble HVEM-mediated KOS/tk12 infection of CHO-K1 cells. Infection was determined by quantitative ONPG assay or X-gal
staining. (A) Infection at increasing concentrations of sHA102 and sHA162 at an MOI of 3. (B) MOI effect on sHA102-mediated infection. (C)%
infected cells at increasing MOIs determined by X-gal staining of sequential 10-fold dilutions of infected cultures. (D) Comparison of sNec1123-
and sHA102-mediated KOS/tk12 entry (MOI = 3). All values are averages of triplicate determinations.
Figure 3 Specificity of sHA102-mediated entry. (A) Comparison of sHA102-mediated CHO-K1 infection by KOS/tk12 and a mutant-gD derivative
impaired for HVEM binding, KOS-Rid1/tk12, at MOIs of 3. (B) Inhibition of sHA102-mediated infection by soluble gD. sHA102 and sgD287 at the
indicated concentrations were incubated with KOS/tk12 virus at 4°C prior to the addition of CHO-K1 cells (MOI = 3) and incubation at 37°C.
Infection was determined by ONPG assay. Values are averages of triplicate determinations.
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Previous reports have shown that HSV enters into CHO
cells expressing human nectin-1 or HVEM via a low
pH-dependent endocytic pathway [27]. To examine
whether the same entry pathway is used in sHA102-
induced HSV-1 infection of CHO-K1 cells, we treated
the cells with hypertonic medium or lysosomotropic
agents. Medium containing 0.3 M sucrose reduced
sHA102-mediated KOS/tk12 infection approximately 5-
fold (Figure 6B), similar to results reported for HSV
infection of HVEM-expressing CHO cells (Figure 6A)
[27], indicating an important role for active endocytosis
in entry mediated by sHA102. To determine whether
endosomal acidification was required for infection,
CHO-K1 cells were pre-treated with increasing concen-
trations of NH4Cl or monensin, and incubated with
KOS/tk12 and sHA102 in the continued presence of
these agents. The results showed no inhibition of
sHA102-mediated infection while infection of CHO-
HVEM cells was sensitive to these agents (Figure 6C,
D). Thus, unlike HSV infection of HVEM-expressing
CHO cells, sHA102-mediated CHO-K1 infection appears
to take place by a low pH-independent endocytic
mechanism.
Discussion
In this study, we demonstrate that a soluble gD receptor
consisting of the N-terminal 102 amino acids of HVEM
is an efficient mediator of HSV-1 infection of receptor-
negative, HSV-resistant CHO-K1 cells. In contrast,
sHA162, comprising the complete HVEM ectodomain,
did not enable viral entry although both sHA102 and
sHA162 blocked virus infection of receptor-bearing CHO
cells. We suggest that sHA162 binds to viral gD but pre-
vents the folding of gD into an active conformation that
can trigger the fusion process. Using inhibitors of recep-
tor- and pH-dependent endocytosis, we obtained evi-
dence that sHA102-mediated infection of CHO-K1 cells
occurs by pH-independent endocytosis, unlike the low
pH-dependent endocytic mechanism responsible for
infection of CHO-HVEM cells [27].
Previous studies have reported inhibition of HSV infec-
tion of CHO-HVEM cells by the soluble ectodomain of
HVEM, alone [HVEM (200 t)] or as a fusion with the Fc
region of rabbit immunoglobulin G (IgG) heavy chain
[6,28]. In a later study, Whitbeck and colleagues also
reported the ability of HVEM (200 t) to promote HSV
entry into receptor-deficient CHO-K1 cells [31].
Although our sHA162 had essentially the same primary
sequence as HVEM (200 t), we did not observe an entry-
promoting effect of sHA162 on CHO-K1 cells. A poten-
tially significant difference with our study is that Whit-
beck et al. [31] used a low speed centrifugation technique
referred to as spinoculation to augment HVEM(200 t)-
mediated virus infection. Spinoculation has been used
with HSV and other enveloped viruses to bring virion
Figure 5 H e p a r i ni n h i b i t i o no fs H A 102-mediated KOS/tk12
entry. Virus and heparin (25 μg/ml) were pre incubated for 30 min
at 4°C, CHO-K1 cells were added, and the incubation was continued
for another 30 min prior to the addition of sHA102 (500 nM),
infection as in previous figures, and ONPG assay. Values are
averages of triplicate determinations.
Figure 4 Inhibition of KOS/tk12 infection of HVEM-expressing CHO cells by soluble HVEM proteins. Increasing amounts of sHA102 (A) or
sHA162 (B) were preincubated with the virus for 1 h at 4°C prior to infection of CHO-HVEM-12 cells (MOI = 1) for 1 h at 37°C. The cells were
washed and infection was measured 7 h later by ONPG assay. Values are averages of triplicate determinations.
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example to bypass receptor-dependent virus attachment
in studies demonstrating soluble receptor-mediated
infection by avian sarcoma and leukosis viruses [35,36].
Since HSV attachment to cells is mediated mainly by
viral envelope proteins other than gD, we performed our
experiments without spinoculation while showing that
heparin-sensitive virus attachment was essential under
these conditions. We observed highly efficient sHA102-
mediated infection (> 80% infection at an MOI of 3), but
entry mediated by the complete soluble ectodomain was
essentially undetectable, suggesting that spinoculation in
the study by Whitbeck et al. [31] had allowed the detec-
tion of HVEM (200 t) activity by concentrating the virus
at the cell surface to raise the sensitivity of the assay.
Nonetheless, the Whitbeck study reported a maximum
HVEM (200 t)-mediated increase in infection of CHO-
K1 cells of 15.5-fold [5 μMH V E M( 2 0 0t ) ;M O I=2 ] ,
substantially less than the increases we observed at lower
sHA102 concentrations (Figure 2). Thus, while sHA162/
HVEM (200 t) may not be inactive in infection of recep-
tor-deficient cells, sHA102 is clearly more effective.
The similar inhibition of CHO-HVEM infection by
sHA102 and sHA162 indicated that the difference in entry-
mediating activity between these two proteins is not due
to differences in gD binding, suggesting that the extra
sequences in sHA162/HVEM(200 t) compared to sHA102
negatively affect the efficiency of gD activation. The pre-
viously reported crystal structure of the gD ectodomain
complexed with the HVEM ectodomain has shown that
the N-terminal region of gD undergoes a conformational
change during HVEM binding [8]. It is conceivable that
sHA102 either induces a more global change in the gD
conformation or that the C-terminal portion of sHA162/
Figure 6 Effect of agents that inhibit endocytic virion uptake or low pH-dependent infection. (A) CHO-A and Vero cells were incubated
with KOS/tk12 (MOI = 3) in hypertonic medium containing 0.3 M sucrose for 1 h at 4°C and infections were performed in the continuous
presence of sucrose followed by ONPG assay. (B) CHO-K1 cells were incubated with KOS/tk12 (MOI = 3) in hypertonic medium containing 0.3 M
sucrose for 1 h at 4°C, sHA102 was added to 500 nM, and infections were performed in the continued presence of sucrose followed by ONPG
assay. (C, D) CHO-K1 cells and CHO-HVEM-12 cells (CHO-A) were pretreated with the indicated amounts of NH4Cl (C) or monensin (D) for 30 min
at 4°C prior to KOS/tk12 attachment at 4°C (MOI = 3), addition of sHA102 to 500 nM (CHO-K1 cells only), and infection as in previous figures in
the continued presence of the respective drugs. Infection was measured by ONPG assay. Values are averages of triplicate determinations.
Baek et al. Virology Journal 2012, 9:15
http://www.virologyj.com/content/9/1/15
Page 6 of 10HVEM(200 t) interferes with the efficient receptor-depen-
dent unmasking of the gD effector/pro-fusion domain pro-
posed by Krummenacher et al. [12] and Fusco et al. [10].
In the absence of gD receptors, HSV is internalized by
CHO cells but fails to enter the cytoplasm and is degraded
in lysosomes [37]. The presence of gD receptors allows
pH-dependent viral capsid escape from endosomes and
release into the cytosol [37]. Whitbeck et al. [31] have
described evidence that HVEM (200 t) “primes” gD for
activation of the membrane fusion machinery, but that a
mildly acidic pH is required in CHO cells as a second sig-
nal for fusion initiation. Surprisingly, our results using
NH4Cl or monensin to neutralize the endosomal pH did
n o ts h o war e d u c t i o ni ns H A 102-mediated infection
although virus uptake by endocytosis was indicated by
reduced infection in media containing 0.3 M sucrose.
Thus it appears that the second signal is not required for
sHA102 activation of gD. At the opposite end, it appears
that endosome acidification as the second signal is not
sufficient for efficient activation of gD by sHA162/HVEM
(200 t). Thus our results suggest that both situations differ
from normal virus entry via full-length HVEM. It is of
interest that several examples have been reported of cell-
surface HVEM failing to serve as a functional HSV entry
receptor [38-40], raising the possibility that these cells lack
a mechanism to counteract interference by CRPs 3 and 4
with gD activation by full-length HVEM. Our study sug-
gests that sHA102 may be an efficient tool to enable HSV
vector-mediated delivery of therapeutic genes to receptor-
deficient cells.
Conclusions
Here we have demonstrated a soluble gD receptor, con-
taining N-terminal 102 amino acids of HVEM, for effi-
cient HSV infection into HSV receptor-negative, HSV-
resistant CHO-K1 cells. This study is consistent with two
other soluble form of gD receptors, sNec1123 and soluble
3-OS HS. We can improve the usage of sHA102 by fusing
it with ligands or receptors of disease related antigens as
a promising molecule for retargeting of natural tropism
of HSV-1. This retargeting strategy can be combined to
create specific recognition by genetic modifications of the
virion envelope for incorporation of targeting moiety.
Methods
Cells and viruses
African green monkey kidney (Vero) cells were obtained
from American Type Culture Collection (ATCC, Rock-
ville, MD) and maintained in Dulbecco’s modification of
Eagle minimal medium (DMEM) supplemented with 10%
fetal bovine serum (FBS). Chinese hamster ovary cells
(CHO-K1, ATCC) were maintained in Ham’s F-12 K med-
ium with 10% FBS, 100 U/ml penicillin, and 100 ug/ml
streptomycin (Invitrogen, Carlsbad, CA). CHO-HVEM-12
cells (Montgomery et al., 1996) are CHO-K1 derivatives
constitutively expressing full-length human HVEM and
were kindly provided by Patricia G. Spear (Northwestern
University, IL, USA). Both cell lines were grown in Ham’s
F-12 K medium supplemented with 10% FBS and 400 μg/
ml G418 (Invitrogen).
Wild-type and mutant gD b-galactosidase reporter
viruses KOS/tk12 and KOS-Rid1/tk12 [29] were kindly
provided by Patricia G. Spear and were propagated and
titered on Vero cells.
Soluble protein expression constructs
Sequences encoding sHA102 and sHA162 were amplified by
PCR on HVEM plasmid pBEC14 ([6]; a kind gift from
Patricia Spear) using the following primers: sHA102/
sHA162 sense primer, 5’-CCC AAG CTT GCC ACC ATG
GAG CCT CCT GGA GAC TGG GGG CC-3’;s H A 102
anti-sense primer, 5’-CCC CTC GAG CTA ATG GTG
ATG GTG ATG GTG AGC GCG GCA CGC GGC GCA-
3’;s H A 162 anti-sense primer, 5’-CCC CTC GAG CTA
GTG GTG GTG GTG GTG GTG GGA GCT GCT GGT
CCC AGC-3’. Primers were designed to provide a Kozak
translational initiation sequence at the start of the open
reading frame (ORF) and six histidine residues followed by
a TAG stop codon at the end. Underlined sequences indi-
cate recognition sites for the restriction enzymes Hind III
and Xho I. Following digestion with Hind III plus Xho I,
each PCR product was cloned into pcDNA3.1 (+) (Invitro-
gen), yielding mammalian expression constructs pHA102
and pHA162.
Expression plasmids for sNec1123 and sgD287 were as
previously described [26].
Production and purification of His fusion proteins
Soluble proteins were expressed in 293 T cells and puri-
fied using the Probond™ resin purification system (Invi-
trogen) according to the manufacturer’sp r o t o c o l .
Briefly, DNA transfections were performed with Lipofec-
tAmine Plus reagent (Invitrogen) and the cells were
then cultured in serum-free media. Culture supernatants
were harvested at 72 h post-transfection, mixed with
Probond resin, and incubated for 1 hr at 4°C. The resin
was washed and bound proteins were eluted.
SDS-PAGE and Western blotting
Purified soluble proteins were electrophoresed on a 12%
polyacrylamide-sodium dodecyl sulfate (SDS) gel and
blotted onto Protran nitrocellulose membrane (Whatman
GmbH, Dassel, Germany). The membrane was blocked
with a solution of 3% skim milk in PBS/0.1% Tween-20,
and incubated for 1 h at room temperature with anti-His
antibody (Santa Cruz Biotechnology, Santa Cruz, CA)
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three times and treated with horseradish peroxide-conju-
gated goat anti-mouse IgG (Sigma, St. Louis, MO) for 1 h
at room temperature. Peroxidase activity was detected
using an ECL kit (Amersham Pharmacia Biotech, Piscat-
away, NJ).
HSV entry assay
CHO-K1 cells in suspension (6 × 10
4 cells/well) were pre-
incubated with KOS/tk12 virus in PBS in a total volume of
40 μl for 1 h at 4°C on a rocking device. Increasing con-
centrations of soluble proteins (0 - 1,000 nM) were added
to the virus/cell mixture and incubated for 1 h at 37°C.
The cells were collected by centrifugation, washed twice
with PBS, resuspended in 40 μl of Ham’s F-12 K medium,
and plated in a single well of a 96 well plate. After contin-
ued incubation at 37°C for 7 h, virus entry was detected by
staining with X-gal (5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside) or by colorimetric assay (ONPG,
o-nitrophenyl-b-D-galactopyranoside), as previously
described [41]. Briefly, infected cell monolayers were fixed
with 0.2% glutaldehyde (Sigma) for 15 min at room tem-
p e r a t u r e( R T ) ,w a s h e dw i t hP B S ,a n di n c u b a t e dw i t h
0.2 mg/ml X-gal (Sigma);% infection was determined by
staining of sequential 10-fold dilutions of infected cells.
For the colorimetric assay, infected monolayers were
washed with PBS and lysed in 150 μl of 1% NP-40, 1 mM
MgCl2,5 0m Mb-mercaptoethanol, and 4 mg/ml ONPG
(Sigma). Lysates were incubated at 37°C until a yellow
color developed, and absorbance was measured at 405 nM.
Infection inhibition by soluble receptors
Different concentrations of soluble receptors (0-2,000
nM) were preincubated with 6 × 10
4 pfu of KOS/tk12 in
a total volume of 40 μl for 1 h at 4°C. CHO-HVEM-12
cells (6 × 10
4 cells/well) were added and the mixture
was incubated for 1 h at 37°C. The cells were then col-
lected, washed twice with PBS, resuspended in 40 μlo f
Ham’s F-12 K medium, and incubated for 7 h at 37°C.
Infection was measured by colorimetric ONPG assay, as
described above.
Infection inhibition by sgD287
Experiments to determine the sensitivity of sHA102-
mediated infection to competition for sHA102 binding with
s o l u b l eg Dw e r ep e r f o r m e de s sentially as described pre-
viously for sNec1123 (Kwon et al., 2006). Briefly, various
amounts of sHA102 and sgD287 were incubated with KOS/
tk12 in PBS for 1 h at 4°C on rocking device. A total of 5 ×
10
5 CHO-K1 cells (MOI = 3) were added and the mixture
was incubated for 1 h at 37°C. The cells were collected,
washed, plated with complete medium, and incubated for
another 7 h. Infection was measured by ONPG assay.
Heparin inhibition
Increasing amounts of KOS/tk12 were preincubated
with 25 μl/ml heparin for 30 min at 4°C, CHO-K1 cells
were added, and the incubation was continued for
another 30 min. sHA102 to a final concentration of 500
nM was then added and the mixture was incubated for
1 h at 37°C. The cells were washed, plated, incubated
with complete medium for 7 h at 37°C, and infection
was determined by ONPG assay.
Endocytosis inhibition assays
KOS/tk12 (MOI = 3) was preincubated with CHO-K1
cells for 30 min at 4°C in the presence of 0.3 M sucrose,
sHA102 (500 nM final concentration) was added, and the
mixture was incubated for 1 h at 37°C. Alternatively,
CHO-K1 cells were incubated with different concentra-
tions of ammonium chloride (NH4Cl) or monensin
( S i g m a )f o r3 0m i na t4 ° C ,v i r u sw a sa d d e da n dt h e
incubation continued for another 30 min at 4°C, and
sHA102 was added with incubation for 1 h at 37°C. In
each situation, the cells were washed, plated, and incu-
bated for 7 h at 37°C in complete medium containing
the respective inhibitory agents. Virus entry was mea-
sured by ONPG assay.
Statistical analysis
All results were performed in triplicate and the values
are expressed as means ± SD. P values were calculated
by using Student’s t test, and statistical significance was
defined as P ≤ 0.05.
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sulfate.
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